Literature DB >> 25244069

Assessing abuse potential of new analgesic medications following market release: an evaluation of Internet discussion of tapentadol abuse.

Emily C McNaughton1, Ryan A Black, Sarah E Weber, Stephen F Butler.   

Abstract

OBJECTIVE: Research on substance abusers in treatment suggests that tapentadol, a prescription analgesic, may have relatively low abuse potential. Messages posted by recreational drug abusers on online forums were examined for amount of discussion and endorsement for abuse of tapentadol and comparator drugs.
METHODS: Internet messages posted between January 1, 2011 and September 30, 2012 on seven drug-abuse web forums were evaluated. Proportions of posts and unique authors discussing tapentadol were compared with eight comparator compounds. Postcontent was coded to compare endorsement for abuse of tapentadol with two comparators, one drug with high desirability for abuse and one with low desirability for abuse.
RESULTS: A total of 1,940,121 messages posted during the study period were copied from selected web forums. The proportion of all posts discussing tapentadol (proportion = 0.0003) was significantly lower than any of the comparator compounds (range of odds ratios from 16.6 to 104.3; P < 0.001). The proportion of unique authors was also lower. Posts coded for endorsement (N =  2,117) yielded an endorsement ratio (Ero) of 2.14 for tapentadol, which was significantly lower than the highly desirable for abuse oxymorphone (ERo = 5.08; P = 0.0011) and was as low as tramadol (ERo = 1.66), which has a long-established profile of low abuse and desirability for abuse.
CONCLUSIONS: Recreational abusers posting on web forums appear to be less interested in abusing tapentadol when compared with other, selected prescription analgesics based on the amount of discussion (i.e., fewer posts and authors mentioning tapentadol). Endorsement of the product for abuse was also low. Wiley Periodicals, Inc.

Entities:  

Keywords:  Abuse Liability; Abuse Risk; Endorsement Ratio; Internet Monitoring; NAVIPPRO; Opioid; Tapentadol

Mesh:

Substances:

Year:  2014        PMID: 25244069     DOI: 10.1111/pme.12547

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  8 in total

1.  "Those edibles hit hard": Exploration of Twitter data on cannabis edibles in the U.S.

Authors:  Francois R Lamy; Raminta Daniulaityte; Amit Sheth; Ramzi W Nahhas; Silvia S Martins; Edward W Boyer; Robert G Carlson
Journal:  Drug Alcohol Depend       Date:  2016-04-26       Impact factor: 4.492

Review 2.  Tapentadol: Can It Kill Two Birds with One Stone without Breaking Windows?

Authors:  Eun Jung Chang; Eun Ji Choi; Kyung Hoon Kim
Journal:  Korean J Pain       Date:  2016-07-01

3.  Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis.

Authors:  Laurie S Anderson; Heidi G Bell; Michael Gilbert; Julie E Davidson; Christina Winter; Monica J Barratt; Beta Win; Jeffery L Painter; Christopher Menone; Jonathan Sayegh; Nabarun Dasgupta
Journal:  JMIR Public Health Surveill       Date:  2017-02-01

4.  Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol.

Authors:  Amy Peacock; Briony Larance; Michael Farrell; Rose Cairns; Nicholas Buckley; Louisa Degenhardt
Journal:  BMJ Open       Date:  2018-03-23       Impact factor: 2.692

5.  Evaluation of Abuse and Route of Administration of Extended-Release Tapentadol Among Treatment-Seeking Individuals, as Captured by the Addiction Severity Index-Multimedia Version (ASI-MV).

Authors:  Suzanne K Vosburg; Jared Beaumont; S Taryn Dailey-Govoni; Stephen F Butler; Jody L Green
Journal:  Pain Med       Date:  2020-09-01       Impact factor: 3.750

6.  Characterizing the Experience of Tapentadol Nonmedical Use: Mixed Methods Study.

Authors:  Suzanne K Vosburg; Taryn Dailey-Govoni; Jared Beaumont; Stephen F Butler; Jody L Green
Journal:  JMIR Form Res       Date:  2022-06-10

7.  How Motivations for Using Buprenorphine Products Differ From Using Opioid Analgesics: Evidence from an Observational Study of Internet Discussions Among Recreational Users.

Authors:  Stephen F Butler; Natasha K Oyedele; Taryn Dailey Govoni; Jody L Green
Journal:  JMIR Public Health Surveill       Date:  2020-03-25

Review 8.  Mining social media for prescription medication abuse monitoring: a review and proposal for a data-centric framework.

Authors:  Abeed Sarker; Annika DeRoos; Jeanmarie Perrone
Journal:  J Am Med Inform Assoc       Date:  2020-02-01       Impact factor: 4.497

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.